{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T07:04:08Z","timestamp":1773903848609,"version":"3.50.1"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000646","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000646","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["26430067"],"award-info":[{"award-number":["26430067"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["17K08599"],"award-info":[{"award-number":["17K08599"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["20H03429"],"award-info":[{"award-number":["20H03429"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpain.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pain"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.jpain.2024.104751","type":"journal-article","created":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T17:19:02Z","timestamp":1732814342000},"page":"104751","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Spinal pituitary adenylate cyclase-activating polypeptide and PAC1 receptor signaling system is involved in the oxaliplatin-induced acute cold allodynia in mice"],"prefix":"10.1016","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6083-1119","authenticated-orcid":false,"given":"Ichiro","family":"Takasaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryota","family":"Nagashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuya","family":"Ashihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoya","family":"Nakamachi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Okada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Toyooka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsuro","family":"Miyata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Kurihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jpain.2024.104751_bib1","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1002\/ana.24951","article-title":"Chemotherapy-induced peripheral neuropathy: a current review","volume":"81","author":"Staff","year":"2017","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jpain.2024.104751_bib2","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.1093\/annonc\/mds208","article-title":"Peripheral neurotoxicity of oxaliplatin in combination with 5-fluorouracil (FOLFOX) or capecitabine (XELOX): a prospective evaluation of 150 colorectal cancer patients","volume":"23","author":"Argyriou","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jpain.2024.104751_bib3","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0093-7754(03)00399-3","article-title":"Oxaliplatin-safety profile: neurotoxicity","volume":"30","author":"Grothey","year":"2003","journal-title":"Semin Oncol"},{"key":"10.1016\/j.jpain.2024.104751_bib4","first-page":"15","article-title":"Safety of oxaliplatin in the treatment of colorectal cancer","volume":"14","author":"Haller","year":"2000","journal-title":"Oncology"},{"key":"10.1016\/j.jpain.2024.104751_bib5","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1056\/NEJMoa032709","article-title":"Multicenter International Study of Oxaliplatin\/5-Fluorouracil\/Leucovorin in the Adjuvant Treatment of Colon Cancer (MOSAIC) Investigators: oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer","volume":"350","author":"Andr\u00e9","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jpain.2024.104751_bib6","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1007\/s00280-019-03957-5","article-title":"Join trial: treatment outcome and recovery status of peripheral sensory neuropathy during a 3-year follow-up in patients receiving modified FOLFOX6 as adjuvant treatment for stage II\/III colon cancer","volume":"84","author":"Yoshino","year":"2019","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.jpain.2024.104751_bib7","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1200\/JCO.2002.07.056","article-title":"Acute oxaliplatininduced peripheral nerve hyperexcitability","volume":"20","author":"Wilson","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jpain.2024.104751_bib8","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1200\/JCO.2013.49.1514","article-title":"Chemotherapy-induced neuropathy and its association with quality of life among 2- to 11 year colorectal cancer survivors: results from the population based profiles registry","volume":"31","author":"Mols","year":"2013","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1016\/j.jpain.2024.104751_bib9","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1634\/theoncologist.2017-0235","article-title":"Pregabalin for the prevention of oxaliplatin-induced painful neuropathy: a randomized, double-blind trial","volume":"22","author":"de Andrade","year":"2017","journal-title":"Oncologist"},{"issue":"13","key":"10.1016\/j.jpain.2024.104751_bib10","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1001\/jama.2013.2813","article-title":"Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial","volume":"309","author":"Smith","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.jpain.2024.104751_bib11","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s00280-018-3664-y","article-title":"Comparative study of the effects of venlafaxine and duloxetine on chemotherapy-induced peripheral neuropathy","volume":"82","author":"Farshchian","year":"2018","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.jpain.2024.104751_bib12","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1007\/s10147-015-0810-y","article-title":"Effect of duloxetine in Japanese patients with chemotherapy-induced peripheral neuropathy: a pilot randomized trial","volume":"20","author":"Hirayama","year":"2015","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.jpain.2024.104751_bib13","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1200\/JCO.20.01399","article-title":"Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: ASCO guideline update","volume":"38","author":"Loprinzi","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jpain.2024.104751_bib14","article-title":"Prevention of oxaliplatin-induced peripheral neuropathy: a systematic review and meta-analysis","volume":"12","author":"Peng","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.jpain.2024.104751_bib15","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1124\/pr.109.001370","article-title":"Pituitary adenylate cyclase-activating polypeptide and its receptors: 20 years after the discovery","volume":"61","author":"Vaudry","year":"2009","journal-title":"Pharmacol Rev"},{"issue":"9","key":"10.1016\/j.jpain.2024.104751_bib16","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.3390\/jcm8091488","article-title":"Pituitary adenylate cyclase-activating polypeptide: 30 years in research spotlight and 600 million years in service","volume":"8","author":"Denes","year":"2019","journal-title":"J Clin Med"},{"key":"10.1016\/j.jpain.2024.104751_bib17","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.pharmthera.2008.11.006","article-title":"VPAC and PAC receptors: from ligands to function","volume":"121","author":"Dickson","year":"2009","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.jpain.2024.104751_bib18","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/0306-4522(93)90018-B","article-title":"Pituitary adenylate cyclase activating peptide is a sensory neuropeptide: immunocytochemical and immunochemical evidence","volume":"57","author":"Moller","year":"1993","journal-title":"Neuroscience"},{"key":"10.1016\/j.jpain.2024.104751_bib19","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0306-4522(94)90025-6","article-title":"Pituitary adenylate cyclase activating polypeptide expression in sensory neurons","volume":"63","author":"Mulder","year":"1994","journal-title":"Neuroscience"},{"key":"10.1016\/j.jpain.2024.104751_bib20","doi-asserted-by":"crossref","DOI":"10.1177\/1744806916646383","article-title":"Spinal astrocytic activation contributes to both induction and maintenance of pituitary adenylate cyclase-activating polypeptide type 1 receptor-induced long-lasting mechanical allodynia in mice","volume":"12","author":"Yokai","year":"2016","journal-title":"Mol Pain"},{"issue":"4","key":"10.1016\/j.jpain.2024.104751_bib21","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.jphs.2016.01.008","article-title":"Pituitary adenylate cyclase-activating polypeptide type 1 receptor signaling evokes long-lasting nociceptive behaviors through the activation of spinal astrocytes in mice","volume":"130","author":"Ohnou","year":"2016","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.jpain.2024.104751_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/jpet.117.245415","article-title":"In silico screening identified novel small-molecule antagonists of PAC1 receptor","volume":"365","author":"Takasaki","year":"2018","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"10.1016\/j.jpain.2024.104751_bib23","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jphs.2018.11.011","article-title":"The novel small-molecule antagonist of PAC1 receptor attenuates formalin-induced inflammatory pain behaviors in mice","volume":"139","author":"Takasaki","year":"2019","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.jpain.2024.104751_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111902","article-title":"Synthesis of a novel and potent small-molecule antagonist of PAC1 receptor for the treatment of neuropathic pain","volume":"186","author":"Takasaki","year":"2020","journal-title":"Eur J Med Chem"},{"issue":"23","key":"10.1016\/j.jpain.2024.104751_bib25","doi-asserted-by":"crossref","first-page":"13355","DOI":"10.1073\/pnas.231094498","article-title":"Altered psychomotor behaviors in mice lacking pituitary adenylate cyclase-activating polypeptide (PACAP)","volume":"98","author":"Hashimoto","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jpain.2024.104751_bib26","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0014-2999(80)90515-4","article-title":"Intrathecal morphine in mice: a new technique","volume":"67","author":"Hylden","year":"1980","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jpain.2024.104751_bib27","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0165-0270(94)90144-9","article-title":"Quantitative assessment of tactile allodynia in the rat paw","volume":"53","author":"Chaplan","year":"1994","journal-title":"J Neurosci Methods"},{"key":"10.1016\/j.jpain.2024.104751_bib28","article-title":"Role of dorsal root ganglion K2p1.1 in peripheral nerve injury-induced neuropathic pain","volume":"2","author":"Mao","year":"2017","journal-title":"Mol Pain"},{"issue":"49","key":"10.1016\/j.jpain.2024.104751_bib29","doi-asserted-by":"crossref","first-page":"9519","DOI":"10.1523\/JNEUROSCI.1223-20.2020","article-title":"Lysophospholipids contribute to oxaliplatin-induced acute peripheral pain","volume":"40","author":"Rimola","year":"2020","journal-title":"J Neurosci"},{"key":"10.1016\/j.jpain.2024.104751_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fpain.2021.683168","article-title":"Impact of dose, sex, and strain on oxaliplatin-induced peripheral neuropathy in mice","volume":"2","author":"Warncke","year":"2021","journal-title":"Front Pain Res"},{"key":"10.1016\/j.jpain.2024.104751_bib31","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0006-8993(95)01150-1","article-title":"Expression of pituitary adenylate cyclase-activating polypeptide in dorsal root ganglia following axotomy: time course and coexistence","volume":"705","author":"Zhang","year":"1995","journal-title":"Brain Res"},{"key":"10.1016\/j.jpain.2024.104751_bib32","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/0306-4522(96)00168-6","article-title":"Pituitary adenylate cyclase activating peptide expression in the rat dorsal root ganglia: up-regulation after peripheral nerve injury","volume":"74","author":"Zhang","year":"1996","journal-title":"Neuroscience"},{"key":"10.1016\/j.jpain.2024.104751_bib33","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1097\/00001756-199808240-00027","article-title":"Pituitary adenylate cyclase activating peptide is upregulated in sensory neurons by inflammation","volume":"9","author":"Zhang","year":"1998","journal-title":"NeuroReport"},{"key":"10.1016\/j.jpain.2024.104751_bib34","doi-asserted-by":"crossref","first-page":"7283","DOI":"10.1523\/JNEUROSCI.0983-04.2004","article-title":"Pituitary adenylate cyclase-activating polypeptide is required for the development of spinal sensitization and induction of neuropathic pain","volume":"24","author":"Mabuchi","year":"2004","journal-title":"J Neurosci"},{"key":"10.1016\/j.jpain.2024.104751_bib35","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0014-2999(96)00359-7","article-title":"Hyperalgesia induced by pituitary adenylate cyclase-activating polypeptide in the mouse spinal cord","volume":"311","author":"Narita","year":"1996","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jpain.2024.104751_bib36","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0304-3959(02)00207-5","article-title":"Modulation of nociceptive transmission by pituitary adenylate cyclase activating polypeptide in the spinal cord of the mouse","volume":"100","author":"Ohsawa","year":"2002","journal-title":"Pain"},{"key":"10.1016\/j.jpain.2024.104751_bib37","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.jpain.2008.01.329","article-title":"Central pituitary adenylate cyclase 1 receptors modulate nociceptive behaviors in both inflammatory and neuropathic pain states","volume":"9","author":"Davis-Taber","year":"2008","journal-title":"J Pain"},{"key":"10.1016\/j.jpain.2024.104751_bib38","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0014-2999(95)00467-5","article-title":"Fragments of pituitary adenylate cyclase activating polypeptide discriminate between type I and II recombinant receptors","volume":"287","author":"Gourlet","year":"1995","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jpain.2024.104751_bib39","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1016\/j.peptides.2007.04.026","article-title":"Class II G protein-coupled receptors for VIP and PACAP: structure, models of activation and pharmacology","volume":"28","author":"Laburthe","year":"2007","journal-title":"Peptides"},{"key":"10.1016\/j.jpain.2024.104751_bib40","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.neuroscience.2014.05.051","article-title":"Astrocytes, but not microglia, are activated in oxaliplatin and bortezomib-induced peripheral neuropathy in the rat","volume":"274","author":"Robinson","year":"2014","journal-title":"Neuroscience"},{"key":"10.1016\/j.jpain.2024.104751_bib41","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/(SICI)1098-1136(199604)16:4<351::AID-GLIA7>3.0.CO;2-2","article-title":"Selective ablation of astrocytes by intracerebral injections of alpha-aminoadipate","volume":"16","author":"Khurgel","year":"1996","journal-title":"Glia"},{"issue":"6950","key":"10.1016\/j.jpain.2024.104751_bib42","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/nature01786","article-title":"P2\u00d74 receptors induced in spinal microglia gate tactile allodynia after nerve injury","volume":"424","author":"Tsuda","year":"2003","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.jpain.2024.104751_bib43","doi-asserted-by":"crossref","first-page":"7527","DOI":"10.4049\/jimmunol.166.12.7527","article-title":"Minocycline provides neuroprotection against N-methyl-D-aspartate neurotoxicity by inhibiting microglia","volume":"166","author":"Tikka","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.jpain.2024.104751_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114160","article-title":"Design and synthesis of pyrido[2,3-d]pyrimidine derivatives for a novel PAC1 receptor antagonist","volume":"231","author":"Takasaki","year":"2022","journal-title":"Eur J Med Chem"},{"issue":"6","key":"10.1016\/j.jpain.2024.104751_bib45","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.neuro.2006.04.010","article-title":"Neurotoxicity of oxaliplatin and cisplatin for dorsal root ganglion neurons correlates with platinum-DNA binding","volume":"27","author":"Ta","year":"2006","journal-title":"Neurotoxicology"},{"issue":"5","key":"10.1016\/j.jpain.2024.104751_bib46","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1152\/jn.2001.85.5.2293","article-title":"A possible explanation for a neurotoxic effect of the anticancer agent oxaliplatin on neuronal voltage-gated sodium channels","volume":"85","author":"Grolleau","year":"2001","journal-title":"J Neurophysiol"},{"issue":"12","key":"10.1016\/j.jpain.2024.104751_bib47","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1158\/2326-6066.CIR-22-0197","article-title":"NET-triggered NLRP3 activation and IL18 release drive oxaliplatin-induced peripheral neuropathy","volume":"10","author":"Lin","year":"2022","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.jpain.2024.104751_bib48","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.redox.2014.01.006","article-title":"Oxidative stress and nerve damage: Role in chemotherapy induced peripheral neuropathy","volume":"2","author":"Areti","year":"2014","journal-title":"Redox Biol"},{"issue":"2","key":"10.1016\/j.jpain.2024.104751_bib49","doi-asserted-by":"crossref","first-page":"198","DOI":"10.3390\/toxics3020198","article-title":"Mitochondrial dysfunction in chemotherapy-induced peripheral neuropathy (CIPN)","volume":"3","author":"Canta","year":"2015","journal-title":"Toxics"},{"issue":"7","key":"10.1016\/j.jpain.2024.104751_bib50","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1111\/j.1460-9568.2004.03644.x","article-title":"Changes in expression of PACAP in rat sensory neurons in response to sciatic nerve compression","volume":"20","author":"Pettersson","year":"2004","journal-title":"Eur J Neurosci"},{"issue":"3","key":"10.1016\/j.jpain.2024.104751_bib51","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/(SICI)1096-9861(20000508)420:3<335::AID-CNE5>3.0.CO;2-#","article-title":"Up-regulation of pituitary adenylate cyclase-activating polypeptide in urinary bladder pathways after chronic cystitis","volume":"420","author":"Vizzard","year":"2000","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.jpain.2024.104751_bib52","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0306-4522(03)00118-0","article-title":"Effect of anti-nerve growth factor treatment on pituitary adenylate cyclase activating polypeptide expression in adult sensory neurons exposed to adjuvant induced inflammation","volume":"120","author":"Jongsma Wallin","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.jpain.2024.104751_bib53","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2021.690858","article-title":"Oxaliplatin depolarizes the IB4-dorsal root ganglion neurons to drive the development of neuropathic pain through TRPM8 in mice","volume":"14","author":"Wu","year":"2021","journal-title":"Front Mol Neurosci"},{"issue":"3","key":"10.1016\/j.jpain.2024.104751_bib54","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1021\/acschemneuro.1c00607","article-title":"A novel progress: glial cells and inflammatory pain","volume":"13","author":"Wang","year":"2022","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.jpain.2024.104751_bib55","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/978-3-662-46450-2_8","article-title":"The role of glia in the spinal cord in neuropathic and inflammatory pain","volume":"227","author":"Old","year":"2015","journal-title":"Handb Exp Pharmacol"},{"issue":"1","key":"10.1016\/j.jpain.2024.104751_bib56","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.pain.2013.06.022","article-title":"Glia and pain: is chronic pain a gliopathy?","volume":"154","author":"Ji","year":"2013","journal-title":"Pain"},{"issue":"4","key":"10.1016\/j.jpain.2024.104751_bib57","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060733","article-title":"Spinal astrocytic activation contributes to mechanical allodynia in a rat chemotherapy-induced neuropathic pain model","volume":"8","author":"Ji","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jpain.2024.104751_bib58","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.expneurol.2014.06.016","article-title":"Glial role in oxaliplatin-induced neuropathic pain","volume":"261","author":"Di Cesare Mannelli","year":"2014","journal-title":"Exp Neurol"},{"key":"10.1016\/j.jpain.2024.104751_bib59","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jpain.2012.11.002","article-title":"Spinal astrocyte gap junctions contribute to oxaliplatin-induced mechanical hypersensitivity","volume":"14","author":"Yoon","year":"2013","journal-title":"J Pain"},{"key":"10.1016\/j.jpain.2024.104751_bib60","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.expneurol.2016.04.022","article-title":"The \u03b19\u03b110 nicotinic receptor antagonist \u03b1-conotoxin RgIA prevents neuropathic pain induced by oxaliplatin treatment","volume":"282","author":"Pacini","year":"2016","journal-title":"Exp Neurol"}],"container-title":["The Journal of Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526590024007296?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526590024007296?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T12:20:31Z","timestamp":1770639631000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526590024007296"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":60,"alternative-id":["S1526590024007296"],"URL":"https:\/\/doi.org\/10.1016\/j.jpain.2024.104751","relation":{},"ISSN":["1526-5900"],"issn-type":[{"value":"1526-5900","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Spinal pituitary adenylate cyclase-activating polypeptide and PAC1 receptor signaling system is involved in the oxaliplatin-induced acute cold allodynia in mice","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pain","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpain.2024.104751","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 \u00a9 Published by Elsevier Inc. on behalf of United States Association for the Study of Pain, Inc","name":"copyright","label":"Copyright"}],"article-number":"104751"}}